Thursday, January 28, 2021

Tokyo’s Nikkei closes down more than 1.5pc after US rout

The Nikkei 225 fell 1.53 per cent, or 437.79 points, to 28,197.42, while the broader Topix index lost 1.14 per cent, or 21.22 points, to 1,838.85. — Reuters pic
The Nikkei 225 fell 1.53 per cent, or 437.79 points, to 28,197.42, while the broader Topix index lost 1.14 per cent, or 21.22 points, to 1,838.85. — Reuters pic

TOKYO, Jan 28 — Tokyo’s benchmark Nikkei index closed down more than 1.5 per cent today with investors disheartened by a bruising session on Wall Street.

The Nikkei 225 fell 1.53 per cent, or 437.79 points, to 28,197.42, while the broader Topix index lost 1.14 per cent, or 21.22 points, to 1,838.85.

Profit-taking dominated the Japanese market after key US indexes lost more than two per cent following mixed earnings from large companies.

“But today’s decline can still be seen as a temporary adjustment following recent gains,” said Toshikazu Horiuchi, a broker at IwaiCosmo Securities.

“Some investors were even buying on dips, which sustained today’s bottom,” Horiuchi told AFP.

He added that the Tokyo market has shifted its focus to the release of earnings by major Japanese companies starting this week.

The dollar fetched ¥104.31(RM4.04) in Asian afternoon trade, higher than ¥104.13 in New York after the US Federal Reserve maintained ultra-loose interest rates.

Fed Chair Jerome Powell cautioned that the US economic outlook was “highly uncertain” in light of surging Covid-19 cases.

Toyota reclaimed the title of the world’s top-selling auto maker in 2020 according to data released by the firm today. It dropped 1.74 per cent to ¥7,397 on profit-taking.

Honda fell 1.56 per cent to ¥2,793 but Nissan gained 1.82 per cent to ¥552.

Sony dropped 2.28 per cent to ¥10,035 with Nintendo down 1.51 per cent at ¥61,660.

Biotech firm JCR Pharmaceuticals, which last month agreed with AstraZeneca to produce its vaccine in Japan, rallied 13.6 per cent to ¥3,115 after the top government spokesman said at least 90 million doses of that vaccine will be produced domestically. — AFP




Source: Malay Mail

No comments:

Post a Comment